Report copyright - MDA19, a novel CB2 agonist, inhibits hepatocellular ... · MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway Mei Rao1,
Please pass captcha verification before submit form